Phibro Animal Health PAHC
NASDAQ PAHC
$35.02 -0.95 (-2.64%)
At close: Nov 16, 2026 · 4:00 PM EST

Phibro Animal Health (PAHC) Depreciation & Amortization (CF) (2013 - 2026)

Updated

Phibro Animal Health's Depreciation & Amortization (CF) came in at $13.58 million for fiscal Q1 2027 (quarter ended Sep 30, 2026), up 5.8% from $12.83 million a year earlier and up 1.7% from the prior quarter.

Analysis

Phibro Animal Health (PAHC) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Phibro Animal Health reported Depreciation & Amortization (CF) of $52.26 million, up 5.7% year-over-year; for FY2026 (ended Jun 30, 2026), it was $51.51 million, up 13.0% from FY2025.

  • Depreciation & Amortization (CF) has increased in each of the last five fiscal years, with a five-year compound annual growth rate of 10.1% (FY2021 to FY2026).
  • Going back by fiscal year, Depreciation & Amortization (CF) was $45.61 million in FY2025 (+26.1%), $36.18 million in FY2024 (+6.4%), $34.01 million in FY2023 (+4.0%) and $32.71 million in FY2022 (+2.6%).
  • The fiscal Q1 2027 figure represents the highest quarterly Depreciation & Amortization (CF) in data going back to fiscal Q3 2013.
  • Year-over-year, Depreciation & Amortization (CF) increased in seven of the last eight quarters, with growth averaging 21.0%.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in fiscal Q1 2026 (growth of 42.5%), and the weakest in fiscal Q3 2026 (a decline of 1.3%).
  • Business Quant data shows PAHC's Depreciation & Amortization (CF) at $13.35 million (Q4 2026), $12.45 million (Q3 2026) and $12.89 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 2.12 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 192.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 1.61 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 132.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 1.58 Bn
10 Phibro Animal Health 1.42 Bn 1.11 Bn 128.54 Mn 13.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 13.58 Mn
Jun 30, 2026 13.35 Mn
Mar 31, 2026 12.45 Mn
Dec 31, 2025 12.89 Mn
Sep 30, 2025 12.83 Mn
Jun 30, 2025 12.41 Mn
Mar 31, 2025 12.62 Mn
Dec 31, 2024 11.57 Mn
Sep 30, 2024 9.00 Mn
Jun 30, 2024 9.20 Mn
Mar 31, 2024 9.20 Mn
Dec 31, 2023 8.91 Mn
Sep 30, 2023 8.87 Mn
Jun 30, 2023 8.57 Mn
Mar 31, 2023 8.49 Mn
Dec 31, 2022 8.50 Mn
Sep 30, 2022 8.45 Mn
Jun 30, 2022 8.41 Mn
Mar 31, 2022 8.45 Mn
Dec 31, 2021 8.00 Mn
API Access

Phibro Animal Health Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PAHC&period=max&api_key=YOUR_API_KEY